Sphingolin is used in adults and in children and adolescents (10 years of age and above) to treat relapsing – remitting multiple sclerosis (MS), more specifically in:
1) Patients who have failed to respond despite treatment with an MS treatment.
2) Patients who have rapidly evolving severe MS.